Compare REPX & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REPX | MGTX |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 587.9M | 665.7M |
| IPO Year | N/A | N/A |
| Metric | REPX | MGTX |
|---|---|---|
| Price | $28.11 | $7.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $36.00 | $23.83 |
| AVG Volume (30 Days) | 209.7K | ★ 422.1K |
| Earning Date | 03-04-2026 | 03-12-2026 |
| Dividend Yield | ★ 5.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.07 | N/A |
| Revenue | ★ $397,398,000.00 | $27,417,000.00 |
| Revenue This Year | $0.59 | N/A |
| Revenue Next Year | $14.96 | $567.62 |
| P/E Ratio | $6.77 | ★ N/A |
| Revenue Growth | N/A | ★ 96.83 |
| 52 Week Low | $21.98 | $4.55 |
| 52 Week High | $36.18 | $9.73 |
| Indicator | REPX | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.86 | 48.51 |
| Support Level | $26.65 | $7.72 |
| Resistance Level | $28.11 | $8.17 |
| Average True Range (ATR) | 1.02 | 0.38 |
| MACD | 0.09 | 0.05 |
| Stochastic Oscillator | 66.10 | 55.76 |
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties and Tennessee Properties, among others.
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.